Company Filing History:
1 out of 170 
1 out of 5,081 
Years Active: 2016
Title: Christopher Mueller: Innovator in Anti-Infectious Compounds
Introduction
Christopher Mueller is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at preventing and treating infectious diseases. His innovative approach combines chemistry and biology to create effective therapeutic solutions.
Latest Patents
Mueller holds a patent for "Mannosylated compounds useful for the prevention and the treatment of infectious diseases." This invention relates to new anti-infectious compounds that consist of a polar head with one to three mannose, dimannose, or trimannose moieties. These are coupled through an appropriate linker to a single lipid chain of at least 17 carbon atoms in length. The patent also includes pharmaceutical compositions and therapeutic uses of these compounds.
Career Highlights
Throughout his career, Christopher Mueller has worked with prestigious institutions such as the Université de Strasbourg and the Centre National de la Recherche Scientifique. His work has focused on advancing the understanding and treatment of infectious diseases through innovative research and development.
Collaborations
Mueller has collaborated with notable colleagues, including Rachid Baati and Laure Dehuyser. These partnerships have contributed to the success of his research and the development of his patented compounds.
Conclusion
Christopher Mueller's contributions to the field of anti-infectious compounds highlight his role as an innovative inventor. His work continues to impact the pharmaceutical industry and offers promising solutions for combating infectious diseases.